TheEdgeResearch
Home / Stocks / RDY

Dr. Reddy's Laboratories Limited (RDY)

NYSE Healthcare Drug Manufacturers - Specialty & Generic
$13.19 ▼ -5.01%
Market Cap
$10.98B
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Beta
0.26
52-Wk Range
12.19-15.67
CEO
Erez Israeli
Country
IN
Currency
USD

Dr. Reddy's Laboratories Limited, alongside its associated companies, functions as a holistic pharmaceutical entity with a global footprint. Its business operations are divided into several key divisions. The Global Generics segment is responsible for the manufacturing and sale of both prescription and over-the-counter finished pharmaceutical products. These offerings are available either under a proprietary brand or as generic formulations that are therapeutically identical to their branded equivalents. This segment also includes the company's biologics ventures. The Pharmaceutical Services a…

Open full interactive analysis & DCF →